Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression

Background: Whilst the link between aging and thrombogenicity in atrial fibrillation (AF) is well established, the cellular underlying mechanisms are unknown. In AF, the role of senescence in tissue remodeling and prothrombotic state remains unclear. Aims: We investigated the link between AF and sen...

Full description

Bibliographic Details
Main Authors: Laurence Jesel, Malak Abbas, Sin-Hee Park, Kensuke Matsushita, Michel Kindo, Hira Hasan, Cyril Auger, Chisato Sato, Patrick Ohlmann, Jean-Philippe Mazzucotelli, Florence Toti, Gilles Kauffenstein, Valérie Schini-Kerth, Olivier Morel
Format: Article
Language:English
Published: MDPI AG 2019-12-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/1/36
id doaj-fec5524e83e84b38a5037573d888c34d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Laurence Jesel
Malak Abbas
Sin-Hee Park
Kensuke Matsushita
Michel Kindo
Hira Hasan
Cyril Auger
Chisato Sato
Patrick Ohlmann
Jean-Philippe Mazzucotelli
Florence Toti
Gilles Kauffenstein
Valérie Schini-Kerth
Olivier Morel
spellingShingle Laurence Jesel
Malak Abbas
Sin-Hee Park
Kensuke Matsushita
Michel Kindo
Hira Hasan
Cyril Auger
Chisato Sato
Patrick Ohlmann
Jean-Philippe Mazzucotelli
Florence Toti
Gilles Kauffenstein
Valérie Schini-Kerth
Olivier Morel
Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression
Journal of Clinical Medicine
atrial fibrillation
senescence
aging
tissue factor
endothelial dysfunction
remodeling
author_facet Laurence Jesel
Malak Abbas
Sin-Hee Park
Kensuke Matsushita
Michel Kindo
Hira Hasan
Cyril Auger
Chisato Sato
Patrick Ohlmann
Jean-Philippe Mazzucotelli
Florence Toti
Gilles Kauffenstein
Valérie Schini-Kerth
Olivier Morel
author_sort Laurence Jesel
title Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression
title_short Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression
title_full Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression
title_fullStr Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression
title_full_unstemmed Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression
title_sort atrial fibrillation progression is associated with cell senescence burden as determined by p53 and p16 expression
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-12-01
description Background: Whilst the link between aging and thrombogenicity in atrial fibrillation (AF) is well established, the cellular underlying mechanisms are unknown. In AF, the role of senescence in tissue remodeling and prothrombotic state remains unclear. Aims: We investigated the link between AF and senescence by comparing the expression of senescence markers (p53 and p16), with prothrombotic and inflammatory proteins in right atrial appendages from patients in AF and sinus rhythm (SR). Methods: The right atrial appendages of 147 patients undergoing open-heart surgery were harvested. Twenty-one non-valvular AF patients, including paroxysmal (PAF) or permanent AF (PmAF), were matched with 21 SR patients according to CHA2DS2-VASc score and treatment. Protein expression was assessed by tissue lysates Western blot analysis. Results: The expression of p53, p16, and tissue factor (TF) was significantly increased in AF compared to SR (0.91 &#177; 0.31 vs. 0.58 &#177; 0.31, <i>p</i> = 0.001; 0.76 &#177; 0.32 vs. 0.35 &#177; 0.18, <i>p</i> = 0.0001; 0.88 &#177; 0.32 vs. 0.68 &#177; 0.29, <i>p</i> = 0.045, respectively). Expression of endothelial NO synthase (eNOS) was lower in AF (0.25 &#177; 0.15 vs. 0.35 &#177; 0.12, <i>p</i> = 0.023). There was a stepwise increase of p53, p16, TF, matrix metalloproteinase-9, and an eNOS progressive decrease between SR, PAF, and PmAF. AF was the only predictive factor of p53 and p16 elevation in multivariate analysis. <i>Conclusions:</i> The study brought new evidence indicating that AF progression is strongly related to human atrial senescence burden and points at a link between senescence, thrombogenicity, endothelial dysfunction and atrial remodeling.
topic atrial fibrillation
senescence
aging
tissue factor
endothelial dysfunction
remodeling
url https://www.mdpi.com/2077-0383/9/1/36
work_keys_str_mv AT laurencejesel atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT malakabbas atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT sinheepark atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT kensukematsushita atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT michelkindo atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT hirahasan atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT cyrilauger atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT chisatosato atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT patrickohlmann atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT jeanphilippemazzucotelli atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT florencetoti atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT gilleskauffenstein atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT valerieschinikerth atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
AT oliviermorel atrialfibrillationprogressionisassociatedwithcellsenescenceburdenasdeterminedbyp53andp16expression
_version_ 1724783288961204224
spelling doaj-fec5524e83e84b38a5037573d888c34d2020-11-25T02:40:04ZengMDPI AGJournal of Clinical Medicine2077-03832019-12-01913610.3390/jcm9010036jcm9010036Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 ExpressionLaurence Jesel0Malak Abbas1Sin-Hee Park2Kensuke Matsushita3Michel Kindo4Hira Hasan5Cyril Auger6Chisato Sato7Patrick Ohlmann8Jean-Philippe Mazzucotelli9Florence Toti10Gilles Kauffenstein11Valérie Schini-Kerth12Olivier Morel13INSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceHôpitaux Universitaires de Strasbourg, Pôle d’Activité Médico-Chirurgicale Cardio-Vasculaire, 67000 Strasbourg, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceHôpitaux Universitaires de Strasbourg, Pôle d’Activité Médico-Chirurgicale Cardio-Vasculaire, 67000 Strasbourg, FranceHôpitaux Universitaires de Strasbourg, Pôle d’Activité Médico-Chirurgicale Cardio-Vasculaire, 67000 Strasbourg, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceINSERM UMR 1260–Regenerative Nanomedecine, FMTS, Université de Strasbourg-Faculté de Pharmacie, 67401 Illkirch-Graffenstaden, FranceBackground: Whilst the link between aging and thrombogenicity in atrial fibrillation (AF) is well established, the cellular underlying mechanisms are unknown. In AF, the role of senescence in tissue remodeling and prothrombotic state remains unclear. Aims: We investigated the link between AF and senescence by comparing the expression of senescence markers (p53 and p16), with prothrombotic and inflammatory proteins in right atrial appendages from patients in AF and sinus rhythm (SR). Methods: The right atrial appendages of 147 patients undergoing open-heart surgery were harvested. Twenty-one non-valvular AF patients, including paroxysmal (PAF) or permanent AF (PmAF), were matched with 21 SR patients according to CHA2DS2-VASc score and treatment. Protein expression was assessed by tissue lysates Western blot analysis. Results: The expression of p53, p16, and tissue factor (TF) was significantly increased in AF compared to SR (0.91 &#177; 0.31 vs. 0.58 &#177; 0.31, <i>p</i> = 0.001; 0.76 &#177; 0.32 vs. 0.35 &#177; 0.18, <i>p</i> = 0.0001; 0.88 &#177; 0.32 vs. 0.68 &#177; 0.29, <i>p</i> = 0.045, respectively). Expression of endothelial NO synthase (eNOS) was lower in AF (0.25 &#177; 0.15 vs. 0.35 &#177; 0.12, <i>p</i> = 0.023). There was a stepwise increase of p53, p16, TF, matrix metalloproteinase-9, and an eNOS progressive decrease between SR, PAF, and PmAF. AF was the only predictive factor of p53 and p16 elevation in multivariate analysis. <i>Conclusions:</i> The study brought new evidence indicating that AF progression is strongly related to human atrial senescence burden and points at a link between senescence, thrombogenicity, endothelial dysfunction and atrial remodeling.https://www.mdpi.com/2077-0383/9/1/36atrial fibrillationsenescenceagingtissue factorendothelial dysfunctionremodeling